Menu

BeyondSPX has rebranded as EveryTicker. We now operate at everyticker.com, reflecting our coverage across nearly all U.S. tickers. BeyondSPX has rebranded as EveryTicker.

Price Performance Heatmap

5Y Price (Market Cap Weighted)

All Stocks (3753)

Company Market Cap Price
GILD Gilead Sciences, Inc.
Trodelvy is a TROP2-targeted antibody-drug conjugate (ADC), a core oncology modality.
$154.99B
$124.94
+3.03%
PFE Pfizer Inc.
Pfizer's vaccines portfolio (e.g., Comirnaty and other RSV vaccines) is a core, revenue-driving product line.
$145.83B
$25.67
-0.85%
SYK Stryker Corporation
Orthopedic devices including implants are a core Stryker product category.
$139.08B
$363.85
+0.38%
BSX Boston Scientific Corporation
Directly sells Cardiology Devices (e.g., WATCHMAN LAAC, ablation catheters, stents) and other interventional cardiology therapies.
$130.50B
$88.08
-2.16%
WELL Welltower Inc.
Healthcare Services & Facilities – Welltower's properties function as healthcare facilities and related operations.
$128.00B
$191.40
+1.71%
MDT Medtronic plc
Medtronic's core cardiovascular devices include leadless pacing, ablation technologies, and related interventional products.
$124.11B
$96.76
-2.26%
VRTX Vertex Pharmaceuticals Incorporated
Vertex is a large-cap pharma/biotech with a diversified, revenue-generating portfolio anchored by CFTR modulators and expanding pipeline.
$113.16B
$441.61
+0.61%
BMY Bristol-Myers Squibb Company
Opdivo is a monoclonal antibody immuno-oncology therapy, a core direct product in BMY's Growth Portfolio.
$112.48B
$55.27
-2.38%
HCA HCA Healthcare, Inc.
HCA operates a large network of hospitals and provides inpatient hospital services.
$109.81B
$469.16
-3.03%
MCK McKesson Corporation
McKesson distributes medical devices and biometrics through its Medical-Surgical Solutions, aligning with the medical devices category.
$104.54B
$840.75
-0.40%
CVS CVS Health Corporation
CVS Health includes health benefits/insurance via Aetna, a core health insurance offering.
$99.69B
$78.59
-3.40%
WM Waste Management, Inc.
WM Healthcare Solutions provides regulated medical waste management and secure information destruction services.
$89.12B
$221.33
+0.67%
ELV Elevance Health Inc.
Direct health insurance provider (Health Insurance) – Elevance Health's core revenue comes from health benefits and risk-sharing with members.
$84.41B
$374.92
-1.84%
REGN Regeneron Pharmaceuticals, Inc.
Regeneron’s core business centers on monoclonal antibody therapeutics (e.g., Dupixent, Libtayo).
$77.69B
$732.71
-1.24%
CI Cigna Corporation
Health insurance products and related services are CI's core offering.
$72.66B
$272.22
-2.06%
MFC Manulife Financial Corporation
Health insurance products via group/employee benefits segments.
$63.47B
$37.36
-0.64%
BDX Becton, Dickinson and Company
BD is a global medical devices & biometrics company with multiple device-based offerings and biometric sensing capabilities.
$59.36B
$207.11
-0.60%
← Previous
1 2 3 4 ... 38
Next →
Showing page 2 of 38 (3753 total stocks)

Loading company comparison...

Loading research report...

MDT Medtronic plc

Medtronic Integrates Precision Neuroscience’s Layer 7 Cortical Interface into StealthStation Surgical Navigation System

Jan 16, 2026
BDX Becton, Dickinson and Company

BD Secures FDA 510(k) Clearance for EnCor EnCompass™ Breast Biopsy System

Jan 15, 2026
BSX Boston Scientific Corporation

Boston Scientific to Acquire Penumbra for $14.5 Billion in Cash‑and‑Stock Deal

Jan 15, 2026
SYK Stryker Corporation

Teledyne FLIR Defense Wins $32 Million Contract to Equip Stryker Infantry Carrier Vehicles with Advanced Recon Kit

Jan 15, 2026
BDX Becton, Dickinson and Company

BDX Invests $110 Million to Expand U.S. Prefilled Syringe Production

Jan 14, 2026
GILD Gilead Sciences, Inc.

Gilead’s Yeztugo Added to CVS Health’s Commercial Plans, Removing Key Payer Barrier

Jan 13, 2026
HCA HCA Healthcare, Inc.

HCA Healthcare Completes MEDITECH Expanse Go‑Live at 43 Hospitals

Jan 13, 2026
BMY Bristol-Myers Squibb Company

Bristol‑Myers Squibb Announces Positive Phase 3 Results for Camzyos in Adolescents with Obstructive Hypertrophic Cardiomyopathy

Jan 12, 2026
BSX Boston Scientific Corporation

Boston Scientific to Acquire Valencia Technologies, Expanding Overactive Bladder Portfolio

Jan 12, 2026
MDT Medtronic plc

Medtronic Receives FDA Clearance for MiniMed Go Smart MDI System, Expanding Pen‑Based Diabetes Care

Jan 12, 2026
PFE Pfizer Inc.

Pfizer Announces Strong Response Rates for BRAFTOVI® in BRAF V600E Metastatic Colorectal Cancer

Jan 10, 2026
PFE Pfizer Inc.

Pfizer Announces Strategic Collaboration with Gordian Bio to Accelerate Obesity Target Discovery

Jan 09, 2026
CI Cigna Corporation

Hunterbrook Media Accuses Cigna of Using Shell Companies to Divert Pharmacy‑Benefit‑Manager Rebates

Jan 07, 2026
PFE Pfizer Inc.

Pfizer Announces Strategic Oncology Collaboration with Cartography Biosciences

Jan 07, 2026
PFE Pfizer Inc.

Pfizer Raises Prices for 80 Drugs Effective Jan. 1, 2026

Jan 06, 2026
SYK Stryker Corporation

VB Spine Completes Acquisition of Stryker’s Cestas, France Manufacturing Facility

Jan 06, 2026
BDX Becton, Dickinson and Company

BD Reports First Phasix Mesh Prophylaxis Case in Greece, Advances PREVENT Trial Enrollment

Jan 05, 2026
GILD Gilead Sciences, Inc.

Gilead Acquires Repare’s Polθ Inhibitor RP‑3467 for Up to $30 Million

Dec 25, 2025
REGN Regeneron Pharmaceuticals, Inc.

Regeneron and Sanofi Gain New Pediatric Asthma Approval for Dupixent in Japan

Dec 24, 2025
PFE Pfizer Inc.

Pfizer Reports Patient Death in Long‑Term Hympavzi Trial, Raising Safety Concerns

Dec 23, 2025
GILD Gilead Sciences, Inc.

Gilead Exercises Option to License Assembly Biosciences’ Herpes Programs, Expanding Antiviral Portfolio

Dec 22, 2025
BMY Bristol-Myers Squibb Company

Bristol‑Myers Squibb to Provide Eliquis Free to Medicaid Patients Under New U.S. Government Agreement

Dec 20, 2025
GILD Gilead Sciences, Inc.

Gilead Secures U.S. Tariff Exemption and $32 B Investment in Exchange for Drug‑Pricing Commitments

Dec 20, 2025
MDT Medtronic plc

Medtronic’s Diabetes Unit MiniMed Files for U.S. IPO, Retains Majority Stake

Dec 20, 2025